Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides

被引:245
作者
Walsh, TR [1 ]
Bolmström, A
Qwärnström, A
Ho, P
Wootton, M
Howe, RA
MacGowan, AP
Diekema, D
机构
[1] Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England
[2] N Bristol NHS Trust, Bristol Ctr Antimicrobial Res & Evaluat, Bristol BS10 5NB, Avon, England
[3] Univ Bristol, Bristol BS10 5NB, Avon, England
[4] Southmead Gen Hosp, Dept Microbiol, Bristol BS10 5NB, Avon, England
[5] AB BIODISK Res Labs, S-16956 Solna, Sweden
[6] Antiinfect Res Ctr, Iowa City, IA USA
关键词
D O I
10.1128/JCM.39.7.2439-2444.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The sensitivity and specificity of seven methods (agar dilution, broth microdilution, Etest at 0.5 and 2.0 McFarland (McF) inocula, two agar screening methods, and population studies [PS]) were evaluated in a double-blind study involving 284 methicillin-resistant Staphylococcus aureus (MRSA) strains and 45 Staphylococcus strains with reduced susceptibilities to vancomycin (SRSV). The results were compared to the population analysis profile-area under the curve ratio method (PAP-AUC ratio compared to that of Mu3) as described by Wootton et al, The agar screening method using brain heart infusion agar (6 mug of vancomycin per mi) gave a sensitivity of 22% and a specificity of 97%. A similar method using Mueller-Hinton agar (5 mug of vancomycin per mi) gave a sensitivity of 20% and a specificity of 99%, The PS method detected 34 false positives (12%) and gave a sensitivity of 71% and a specificity of 88%. Etest using 0.5 and 2.0 McF inocula gave sensitivities and specificities of 82 and 93% and of 96 and 97%, respectively. The best Etest interpretative criteria for the 2.0 McF inoculum was greater than or equal to8 mg of vancomycin per liter and greater than or equal to8 mug teicoplanin per mi or greater than or equal to 12 mug of teicoplanin per mi. The direct colony suspension inoculum for this method was found to be equally accurate in detecting (hetero-) glycopeptide-intermediate S. aureus compared to the overnight broth inoculum preparation method. Agar dilution and broth microdilution using the NCCLS breakpoint criteria for vancomycin gave sensitivities and specificities of 20 and 100% and of 11 and 100%, respectively, Using the Etest with a 2.0 McF inoculum, six different media were assessed against a selection of SRSV (n = 48) and MRSA (n = 12). Brain heart infusion agar yielded the highest sensitivity and specificity values: 88 and 88%, respectively.
引用
收藏
页码:2439 / 2444
页数:6
相关论文
共 22 条
[1]  
[Anonymous], 1981, STAT METHODS RATES P
[3]   CHARACTERIZATION OF AN ISOGENIC SET OF METHICILLIN-RESISTANT AND SUSCEPTIBLE MUTANTS OF STAPHYLOCOCCUS-AUREUS [J].
BERGERBACHI, B ;
STRASSLE, A ;
KAYSER, FH .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (06) :697-701
[4]   Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany [J].
Bierbaum, G ;
Fuchs, K ;
Lenz, W ;
Szekat, C ;
Sahl, HG .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) :691-696
[5]   Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates [J].
Boyle-Vavra, S ;
Berke, SK ;
Lee, JC ;
Daum, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :272-277
[6]  
*BRIT SOC ANT CHEM, 1998, BSAC NEWS SPR, P9
[7]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR MORB MORTAL WKL, V46, P765
[8]   Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area [J].
Geisel, R ;
Schmitz, FJ ;
Thomas, L ;
Berns, G ;
Zetsche, O ;
Ulrich, B ;
Fluit, AC ;
Labischinsky, H ;
Witte, W .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (06) :846-848
[9]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[10]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136